Clinical

Dataset Information

0

Phase I study of the preventive effect of Kampo medicine on oxaliplatin-induced peripheral neurotoxicity

ABSTRACT: Interventions: During XELOX regimen, Kampo medicine is administered as follows: Level 1(TJ-18 7.5g, TJ-3023 0g), Level 2(TJ-18 7.5g, TJ-3023 1.5g), Level 3(TJ-18 7.5g, TJ-3023 3.0g) Primary outcome(s): Decision of DLT, MTD, RD of Kampo medicine (TJ-3023, TJ-18) Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2631410 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical Preventive effect of Bushimatsu and Keishikajubutou on peripheral neurotoxicity of Oxaliplatin(L-OHP) therapy: a phase II clinical study.
| 2646318 | ecrin-mdr-crc
Clinical Preventive effect of Bushimatsu and Keishikajutsubuto on peripheral neurotoxicity of Oxaliplatin(L-OHP) therapy: a phase II clinical study.
| 2615226 | ecrin-mdr-crc
Clinical Preventive Effect of Goshajinkigan on Peripheral Neurotoxicity of FOLFOX Therapy :A Placebo-controlled Double-blind Randomized Phase III Study
| 2619732 | ecrin-mdr-crc
Genomics IGNITE: Genomic Medicine Implementation - The Personalized Medicine Program
| PRJNA606620 | ENA
Genomics IGNITE: Genomic Medicine Implementation - The Personalized Medicine Program
| PRJNA606621 | ENA
Transcriptomics Expression data of 8 healthy people and 8 patients with coronary heart disease before and after 8 weeks treatment with Danlou tablets
2023-06-14 | GSE179789 | GEO
Genomics medicine metagenome
| PRJNA884878 | ENA
Genomics medicine metagenome
| PRJNA903771 | ENA
Genomics traditional chinese medicine
| PRJNA796441 | ENA
Transcriptomics A Japanese herbal medicine, Hochuekkito (TJ-41), has anti-inflammatory effects on the COPD mouse model
2024-05-15 | GSE239537 | GEO